709 related articles for article (PubMed ID: 18263584)
1. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.
Buggia-Prevot V; Sevalle J; Rossner S; Checler F
J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations.
Chami L; Buggia-Prévot V; Duplan E; Del Prete D; Chami M; Peyron JF; Checler F
J Biol Chem; 2012 Jul; 287(29):24573-84. PubMed ID: 22654105
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
4. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.
Alves da Costa C; Sunyach C; Pardossi-Piquard R; Sévalle J; Vincent B; Boyer N; Kawarai T; Girardot N; St George-Hyslop P; Checler F
J Neurosci; 2006 Jun; 26(23):6377-85. PubMed ID: 16763046
[TBL] [Abstract][Full Text] [Related]
5. Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.
Lefranc-Jullien S; Lisowski V; Hernandez JF; Martinez J; Checler F
Br J Pharmacol; 2005 May; 145(2):228-35. PubMed ID: 15753947
[TBL] [Abstract][Full Text] [Related]
6. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
7. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
8. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
10. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
11. Melatonin ameliorates Aβ
Chinchalongporn V; Shukla M; Govitrapong P
J Pineal Res; 2018 May; 64(4):e12470. PubMed ID: 29352484
[TBL] [Abstract][Full Text] [Related]
12. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
Ly PT; Wu Y; Zou H; Wang R; Zhou W; Kinoshita A; Zhang M; Yang Y; Cai F; Woodgett J; Song W
J Clin Invest; 2013 Jan; 123(1):224-35. PubMed ID: 23202730
[TBL] [Abstract][Full Text] [Related]
14. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid beta peptide generation.
Lakshmana MK; Yoon IS; Chen E; Bianchi E; Koo EH; Kang DE
J Biol Chem; 2009 May; 284(18):11863-72. PubMed ID: 19251705
[TBL] [Abstract][Full Text] [Related]
15. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H; Capell A; Leimer U; Haass C
Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
[TBL] [Abstract][Full Text] [Related]
16. p53-dependent control of transactivation of the Pen2 promoter by presenilins.
Dunys J; Sevalle J; Giaime E; Pardossi-Piquard R; Vitek MP; Renbaum P; Levy-Lahad E; Zhang YW; Xu H; Checler F; da Costa CA
J Cell Sci; 2009 Nov; 122(Pt 21):4003-8. PubMed ID: 19889971
[TBL] [Abstract][Full Text] [Related]
17. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
18. Mutant presenilin 1 increases the expression and activity of BACE1.
Giliberto L; Borghi R; Piccini A; Mangerini R; Sorbi S; Cirmena G; Garuti A; Ghetti B; Tagliavini F; Mughal MR; Mattson MP; Zhu X; Wang X; Guglielmotto M; Tamagno E; Tabaton M
J Biol Chem; 2009 Apr; 284(14):9027-38. PubMed ID: 19196715
[TBL] [Abstract][Full Text] [Related]
19. beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein.
Yamakawa H; Yagishita S; Futai E; Ishiura S
J Biol Chem; 2010 Jan; 285(3):1634-42. PubMed ID: 19926793
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
